city New Delhi India hospital covid-19 city New Delhi India

Covid-19 treatment: FDC launches Favipiravir oral suspension in India

Reading now: 546
www.livemint.com

NEW DELHI : Pharma firm FDC Ltd on Monday said it has launched oral suspension of Favipiravir to treat mild to moderate cases of COVID-19 in the country.

This prescription-only Favenza oral suspension is currently available at all retail medical outlets and hospital pharmacies across India, FDC said in a statement.

Convenient loading dosage of the oral suspension helps reduce dosage frequency, it added. "With positive cases on the rise again, now is the time to provide healthcare warriors in our country with viable options in this continuous battle against this disease.

In order to combat Covid-19, we believe in offering best efficacy along with convenience to our patients and as such we have focused our efforts in making the process

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA